|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0492 SEK | +8.37% |
|
-4.65% | +6.96% |
Eurocine Vaccines AB (publ) reported earnings results for the full year ended June 30, 2023. For the full year, the company reported revenue was SEK 0.005 million compared to SEK 0.07 million a year ago. Net loss was SEK 18.35 million compared to SEK 20.15 million a year ago.
Basic loss per share from continuing operations was SEK 0.758 compared to SEK 1.4 a year ago. Diluted loss per share from continuing operations was SEK 0.758 compared to SEK 1.4 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +6.96% | 882K | |
| +33.63% | 50.93B | |
| -0.09% | 42.12B | |
| +49.62% | 42.05B | |
| -4.96% | 29.18B | |
| +11.18% | 26.02B | |
| -21.95% | 18.9B | |
| +8.61% | 13.21B | |
| +28.31% | 12.16B | |
| +24.73% | 12.17B |
EUROCINE VACCINES AB 
